XML 49 R21.htm IDEA: XBRL DOCUMENT
v3.23.3

ASSOCIATE MEDICAL BENEFITS | 12 Months Ended
--- | ---
Sep. 30, 2023
Defined Benefit Plan, Postretirement Medical Plan with Prescription Drug Benefits [Abstract] |
ASSOCIATE MEDICAL BENEFITS | ASSOCIATE MEDICAL BENEFITS The Company provides comprehensive major medical benefits to its associates. The Company is self-insured for certain health benefits up to $1.0 per occurrence per individual. The cost of such benefits is recognized as expense in the period the claim is incurred and was $40.1, $46.6 and $43.7 in fiscal 2023, fiscal 2022 and fiscal 2021, respectively. The Company also provides comprehensive major medical benefits to certain retired associates and their dependents. Substantially all of the Company’s domestic associates who were hired before January 1, 1998 become eligible for these benefits if they retire at age 55 or older with more than ten years of service. The retiree medical plan requires certain minimum contributions from retired associates and includes provisions to limit the overall cost increases the Company is required to cover. The Company funds its portion of retiree medical benefits as claims are paid. The following tables set forth information about the retiree medical plan for domestic associates. The retiree medical plan is valued using a September 30 measurement date.
| 2023 |  | 2022
Change in Accumulated Plan Benefit Obligation (“APBO”): |  |  |
Benefit obligation at beginning of year | $ | 15.7 |  |  | $ | 20.1 |
Service cost | 0.1 |  |  | 0.2 |
Interest cost | 0.8 |  |  | 0.5 |
Plan participants’ contributions | 0.4 |  |  | 0.4 |
Actuarial gain | (2.2) |  |  | (4.0) |
Curtailment loss | — |  |  | 0.6 |
Benefits paid | (1.5) |  |  | (2.1) |
Benefit obligation at end of year | $ | 13.3 |  |  | $ | 15.7 |
Change in plan assets: |  |  |
Fair value of plan assets at beginning of year | $ | — |  |  | $ | — |
Employer contribution | 1.1 |  |  | 1.7 |
Plan participants’ contributions | 0.4 |  |  | 0.4 |
Gross benefits paid | (1.5) |  |  | (2.1) |
Fair value of plan assets at end of year | $ | — |  |  | $ | — |
Unfunded status at end of year | $ | (13.3) |  |  | $ | (15.7) |
| 2023 |  | 2022
Amounts recognized in the Consolidated Balance Sheets consist of: |  |  |
Current liabilities | $ | (1.4) |  |  | $ | (1.6) |
Non-current liabilities | (11.9) |  |  | (14.1) |
Total amount accrued | $ | (13.3) |  |  | $ | (15.7) |
Amounts recognized in AOCL consist of: |  |  |
Actuarial (gain) loss | $ | (3.4) |  |  | $ | (1.2) |
Prior service credit | — |  |  | (0.2) |
Total accumulated other comprehensive (income) loss | $ | (3.4) |  |  | $ | (1.4) |
Total change in other comprehensive loss attributable to: |  |  |
Gain during the period | $ | 2.2 |  |  | $ | 3.4 |
Reclassification to net earnings | (0.2) |  |  | (0.9) |
Total change in other comprehensive loss | $ | 2.0 |  |  | $ | 2.5 |
Discount rate used in development of APBO | 5.98 | % |  | 5.60 | %
Net periodic benefit cost (income) was $0.7, $(0.2) and $(0.2) during fiscal 2023, fiscal 2022 and fiscal 2021, respectively. For measurement as of September 30, 2023, management has assumed that health care costs will increase at an annual rate of 7.00%, and thereafter decreasing to an ultimate trend rate of 5.00% in 2028. The following benefit payments under the plan are expected to be paid by the Company and the retirees for the fiscal years indicated:
| Gross Benefit Payments |  | Retiree Contributions |  |  |  | Net Company Payments
2024 | $ | 1.8 |  |  | $ | (0.4) |  |  |  |  | $ | 1.4 |
2025 | 1.8 |  |  | (0.4) |  |  |  |  | 1.4 |
2026 | 1.9 |  |  | (0.5) |  |  |  |  | 1.4 |
2027 | 1.9 |  |  | (0.6) |  |  |  |  | 1.4 |
2028 | 2.0 |  |  | (0.7) |  |  |  |  | 1.3 |
2029 – 2033 | 9.8 |  |  | (3.8) |  |  |  |  | 6.0 |

X
- Definition Entire disclosure for postretirement medical plans that contain prescription drug coverage. + References No definition available. + Details
Name: | smg_AssociateMedicalBenefitsTextBlock
Namespace Prefix: | smg_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_PostretirementMedicalPlansWithPrescriptionDrugBenefitsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration